Delee Corp logo

Delee Corp

Enabling radical solutions for science and medicine

15 employees · est. 2017 · California, United States

VS
IV Diagnostics logo

IV Diagnostics

Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management

est. 2012

IV Diagnostics is the older company (2017 vs 2012).

Side-by-Side Comparison

Delee Corp IV Diagnostics
Founded
2017 2012 older
Headquarters
California, United States Not tracked yet
Employees
15 Not tracked yet
Industry
Health Care, Medical Devices, Machine Learning Biotechnology, Health Care, Platforms
Funding Stage
Equity Crowdfunding Private Equity
Total Funding
$2.37M $1.19M
Funding Rounds
4 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Cancer Detection, Circulating Tumor Cells, Early Detection, Prognosis, Disease Management, Metastatic Diseases, Cancer Stem Cells, Tumorigenic, Metastasis, Recurrence, Diagnostic Targets, Bloodstream, Primary Tumors, Quantifying CTCs, Characterization Of CTCs
Website
delee.co ivdiagnostics.com
Delee Corp logo

About Delee Corp

Delee is a medical device company founded in 2016, with a focus on revolutionizing early cancer diagnosis and management. Their flagship product, CytoCatch™, boasts a patent-pending technology catered to a CTC blood-based assay, aiming to facilitate the early detection of cancer and monitor the effi...

IV Diagnostics logo

About IV Diagnostics

IV Diagnostics, founded in 2012 , is a biotechnology startup focused on advancing early cancer detection using circulating tumor cells (CTCs) for improved prognosis and disease management. The company's slogan, "Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis an...

We will tell you when either one moves

BounceWatch watches Delee Corp and IV Diagnostics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Delee Corp and IV Diagnostics — by email.

Frequently Asked Questions

Delee Corp — Enabling radical solutions for science and medicine. IV Diagnostics — Advancing Early Cancer Detection with Circulating Tumor Cells for Improved Prognosis and Disease Management. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Delee Corp has raised $2.37M while IV Diagnostics has raised $1.19M.
Delee Corp and IV Diagnostics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Delee Corp with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Delee Corp on 12 Sep 2024, and IV Diagnostics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy